Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of TDF Combinations in Children
NCT00260078Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Feb 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label trial of tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV) (3 arms), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoints: Predosage concentration and Area under the concentration-time curve. Started Feb 2006; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00260078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00260078.